<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05072652</url>
  </required_header>
  <id_info>
    <org_study_id>00003289</org_study_id>
    <nct_id>NCT05072652</nct_id>
  </id_info>
  <brief_title>Short Term Immobilization of the Lower Limb</brief_title>
  <acronym>STILL</acronym>
  <official_title>Short-term Immobilization and Rehabilitation of the Lower Limb: Changes in Strength, Size, and Neuromuscular Function</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Central Florida</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Central Florida</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the effects of one week of knee-joint&#xD;
      immobilization on muscle size, strength, neuromuscular function, and brain function. In&#xD;
      addition, the effects of two different interventions (i.e., neuromuscular electrical&#xD;
      stimulation and action observation/mental imagery) throughout immobilization will be&#xD;
      determined. Following the immobilization period, participants that have lost strength will be&#xD;
      rehabilitated with twice weekly resistance training sessions, and sex-based differences in&#xD;
      rehabilitation timelines will be examined.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study will utilize a repeated measures design in healthy adults aged 18-40 years. After&#xD;
      a thorough familiarization visit, muscular size, strength, neuromuscular responses, and&#xD;
      corticospinal excitability/inhibition will be measured before (PRE) and after (POST) one week&#xD;
      of unilateral knee joint immobilization of the left leg. Four groups will be examined: 1)&#xD;
      immobilization only, 2) immobilization + daily neuromuscular electrical stimulation, 3)&#xD;
      immobilization + daily action observation/mental imagery training, 4) a control group.&#xD;
      Throughout the immobilization period, participants will be in a leg brace locked at 90&#xD;
      degrees knee flexion. They will perform daily range of motion exercises and wear a&#xD;
      compression sock at all times to mitigate the risk of blood clots. Following completion of&#xD;
      the immobilization period, participants that have lost strength will complete a supervised&#xD;
      rehabilitation program of twice weekly lower body resistance training sessions until they&#xD;
      have returned to baseline levels of strength. Group assignment will be randomized and blocked&#xD;
      on sex to ensure an equal number of participants within each group consisting of a relatively&#xD;
      equal number of males and females.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 11, 2021</start_date>
  <completion_date type="Anticipated">June 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">June 1, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Repeated measures design</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Muscular strength</measure>
    <time_frame>15 minutes</time_frame>
    <description>Changes in muscular strength will be measured via maximal voluntary contraction torque</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Muscular size</measure>
    <time_frame>10 minutes</time_frame>
    <description>Changes in muscular size will be measured via ultrasonography of the quadriceps</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Corticospinal responses</measure>
    <time_frame>30 minutes</time_frame>
    <description>Corticospinal responses will be measured with transcranial magnetic stimulation targeting the lower limbs</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Motor unit behavior</measure>
    <time_frame>10 minutes</time_frame>
    <description>Motor unit recruitment threshold and firing rate will be measured with surface electromyography signals detected from the quadriceps</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Voluntary activation</measure>
    <time_frame>15 minutes</time_frame>
    <description>Voluntary activation will be measured using the interpolated twitch technique</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Rate of recovery</measure>
    <time_frame>1.5 hours per session</time_frame>
    <description>The time taken to recover strength lost will be measured via number of resistance training sessions needed after immobilization</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Compliance</measure>
    <time_frame>one week</time_frame>
    <description>Compliance will be measured via the use of accelerometers around both ankles. Compliance will be calculated as the number of participants that following the crutch/brace protocol as described.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physical activity (Step count)</measure>
    <time_frame>one week</time_frame>
    <description>Physical activity will be assessed via step counts and compared to changes in primary outcome measures via accelerometers around both ankles</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Weakness, Muscle</condition>
  <condition>Muscle Weakness</condition>
  <condition>Muscle Loss</condition>
  <condition>Muscle Atrophy</condition>
  <condition>Injury, Knee</condition>
  <arm_group>
    <arm_group_label>Immobilization</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants in the immobilization groups will undergo one week of unilateral knee joint immobilization of the left leg.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>The control group will not undergo any intervention.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Neuromuscular Electrical Stimulation</intervention_name>
    <description>Participants in this group will perform twice daily neuromuscular electrical stimulation training sessions of the quadriceps muscles (specifically, the vastus lateralis and rectus femoris) or the immobilized left leg.</description>
    <arm_group_label>Immobilization</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Action Observation + Mental Imagery</intervention_name>
    <description>Participants in this group will perform daily action observation + mental imagery training via video and audio recordings.</description>
    <arm_group_label>Immobilization</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Healthy men and women between the ages of 18-40 years&#xD;
&#xD;
          -  Body mass index &gt;20 kg/m2 or &lt; 35 kg/m2&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Body mass index &lt;20 kg/m2 or &gt; 35 c&#xD;
&#xD;
          -  Experience of major joint pain/discomfort of the upper or lower limbs, back, or neck&#xD;
             within the previous six months.&#xD;
&#xD;
          -  History of major musculoskeletal injury or surgery&#xD;
&#xD;
          -  Neuromuscular disease (e.g., Parkinson's, MS, ALS)&#xD;
&#xD;
          -  Metabolic disease (e.g., diabetes, thyroid disorder, metabolic syndrome)&#xD;
&#xD;
          -  Personal or family history of blood clots&#xD;
&#xD;
          -  Trouble using or controlling one's muscles&#xD;
&#xD;
          -  History of cancer&#xD;
&#xD;
          -  History of stroke&#xD;
&#xD;
          -  History of heart attack&#xD;
&#xD;
          -  History of arthritis&#xD;
&#xD;
          -  Use of an assistive walking device or mobility aids within the past six months&#xD;
&#xD;
          -  Use of anabolic steroids within the past six months&#xD;
&#xD;
          -  History of convulsions, seizures, or syncope&#xD;
&#xD;
          -  History of concussion as diagnosed by a physician&#xD;
&#xD;
          -  Certain medications (e.g., muscle relaxants, benzodiazepines)&#xD;
&#xD;
          -  Very thick hair or certain hairstyles that would impede the TMS coil from making&#xD;
             direct contact with the scalp&#xD;
&#xD;
          -  Allergy to rubbing alcohol&#xD;
&#xD;
          -  Lack of transportation to and from the laboratory&#xD;
&#xD;
          -  Implant of any kind&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Allergy to silver&#xD;
&#xD;
          -  Diagnosis of any psychiatric condition&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Participants enrolled in this study must self identify with their biological sex at birth</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Matt S Stock, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Central Florida</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kylie K Harmon, PhD(c)</last_name>
    <phone>407-823-0364</phone>
    <email>npl@ucf.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ryan M Girts, PhD(c)</last_name>
    <phone>407-823-0364</phone>
    <email>npl@ucf.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Central Florida</name>
      <address>
        <city>Orlando</city>
        <state>Florida</state>
        <zip>32816</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://healthprofessions.ucf.edu/research/studies/</url>
    <description>Related Info</description>
  </link>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>September 28, 2021</study_first_submitted>
  <study_first_submitted_qc>September 28, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 11, 2021</study_first_posted>
  <last_update_submitted>October 29, 2021</last_update_submitted>
  <last_update_submitted_qc>October 29, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 3, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Central Florida</investigator_affiliation>
    <investigator_full_name>Matt Stock</investigator_full_name>
    <investigator_title>Associate Professor of Physical Therapy</investigator_title>
  </responsible_party>
  <keyword>immobilization</keyword>
  <keyword>muscle atrophy</keyword>
  <keyword>muscle strength</keyword>
  <keyword>action observation</keyword>
  <keyword>mental imagery</keyword>
  <keyword>neuromuscular electrical stimulation</keyword>
  <keyword>rehabilitation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Muscle Weakness</mesh_term>
    <mesh_term>Muscular Atrophy</mesh_term>
    <mesh_term>Atrophy</mesh_term>
    <mesh_term>Knee Injuries</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>IPD will be shared by the PI upon reasonable request. Personal identifiable information will not be shared; however, physiological data and outcome measures may be shared if requested.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_time_frame>Data will be made available upon reasonable request after the time of study completion and manuscript publication</ipd_time_frame>
    <ipd_access_criteria>To access IPD, please contact the study PI.</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

